Management of Blood Pressure in Patients with Operated Aortic Aneurysm

Blood Pressure Targets

The American Heart Association recommends a blood pressure target of systolic pressure <130 mmHg and diastolic pressure <80 mmHg for patients with operated aortic aneurysm, with consideration of more intensive control towards <120 mmHg systolic if tolerated, to reduce cardiovascular events and prevent residual aortic complications 1, 2.
For patients with abdominal aortic aneurysm (AAA), the primary target is systolic pressure <130 mmHg and diastolic pressure <80 mmHg to reduce cardiovascular events, including myocardial infarction and stroke, and prevent rupture of residual aortic segments 1.
Selected patients without diabetes who are not undergoing new surgical repair may benefit from intensive control with systolic pressure <120 mmHg, based on data from the SPRINT study showing a 25% reduction in cardiovascular events and 27% reduction in all-cause mortality 1.

Beta-blockers are reasonable as first-line therapy to achieve blood pressure targets in patients with operated thoracic aortic aneurysm (TAA), regardless of cause and in the absence of contraindications, as recommended by the American College of Cardiology 2.
For patients with Marfan syndrome who have undergone surgery, beta-blockers are recommended to reduce the rate of residual aortic dilation, with evidence from randomized trials showing attenuation of expansion during 10-year follow-up 3.

Even after repair of the ascending aorta, patients with aneurysm (especially Marfan syndrome) remain at risk of residual aortic dissection, justifying lifelong strict blood pressure control, as warned by the European Society of Cardiology 4, 5.
Uncontrolled hypertension is a known risk factor for aortic rupture and dissection, making aggressive blood pressure control essential even in asymptomatic post-operative patients, as emphasized by the American Heart Association 1, 2, 3.

High variability of blood pressure is an independent risk factor for the prognosis of aortic dissection, so consistent control should be sought, not just adequate average values, as noted by the American College of Cardiology 6.
Lifelong follow-up with imaging of the entire aorta (echocardiography, magnetic resonance imaging, or computed tomography) is required to detect progressive dilation of residual segments, as recommended by the European Society of Cardiology 4, 5.

Beta‑blockers reduce shear stress on the aortic wall and may attenuate dilation of residual aortic segments – evidence from a 2022 Circulation study. 7
The American Heart Association considers adding an angiotensin‑II receptor blocker (ARB) to beta‑blocker therapy to be reasonable (Class IIa recommendation) – based on the same 2022 Circulation publication. 7

Lifelong imaging of the entire aorta (ultrasound, magnetic resonance imaging, or computed tomography) is required to detect progressive dilation of residual aortic segments – recommendation from a 2013 Journal of the American College of Cardiology article. 8
Periodic surveillance after endovascular repair should monitor for endoleaks, document reduction or stability of the excluded aneurysm sac, and determine the need for additional intervention – supported by a 2006 Circulation study and reinforced by the 2013 JACC article. [9][8]